noteworthy considering that none of the previously reported
examples of intramolecular electrophilic aromatic substitution
reactions employ unsaturated aldehydes as the electrophile3
and only one cyclization of an unsaturated carbonyl com-
pound that lacked carbocation stabilizing groups on the
â-carbon (a 7-endo ketone) has been reported.3h Thus, as
we had planned, the amide moiety may be exo to the incipient
ring (entries 1-7) or endo to afford lactams (entries 8 and
9). To date, a tetrahydroisoquinoline (entry 1), as well as
3-benzazepines (entries 2-5 and 8) and 3-benzazocines
(entries 6 and 9) have been prepared using this method. The
reaction times indicate that a seven-membered ring closure
is preferred over the six- and eight-membered counterparts
(entry 2 vs. entry 1 and entry 8 vs. entry 9) in keeping with
molecular modeling that suggests a more accessible Wheland
intermediate for a seven-membered closure. Not surprisingly,
the cyclizations with the more electron-withdrawing trifla-
midoacroleins are more facile than the acetamido or benz-
amido variants and, consequently, can be catalyzed with a
milder Lewis acid (SnCl4) in substoichiometric quantities
(entry 5 vs. entries 2 and 4). Moreover, activated aromatic
rings are not essential for successful cyclization, although
more forcing conditions are required (entry 3 vs. entry 2).
Finally, the example shown in entry 7 demonstrates that
aromatic ring systems other than substituted benzenes
participate in this type of cyclization en route to uncommon
heterocyclic ring systems.
Scheme 3
moiety and removal of the triflamide group6 was ac-
complished by treatment of benzazocine 12 with lithium
aluminum hydride. The resulting secondary amine was
methylated using the standard reductive amination protocol,
and the methyl ether of the product 13 was cleaved with
boron tribromide to provide morphine analogue 14. Morphine
analogue 16 was obtained by initial decarbonylation of
benzazocine 12 using the Wilkinson reagent in refluxing
xylene to afford the triflamide 15, which was then subjected
to the same three-step sequence used to prepare analogue
14.8
In summary, we have shown that intramolecular aromatic
substitution reactions of amidoacroleins constitute a new
strategy for preparing heterocyclic compounds that embody
the biologically significant â-phenethylamine substructure.
The three-component aspect of this methodology, i.e., 1,3-
dioxin-5-one, primary amine, and acylating/sulfonylating
agent, makes it readily adaptable to natural product total
synthesis endeavors. Several possibilities are under consid-
eration and will be reported in due course.
To demonstrate that this methodology is indeed capable
of providing compounds possessing â-phenethylamine phar-
macophores, the product of entry 6, benzazocine 12 (Scheme
3), was converted to the new morphine analogues 14 and
16.7 To that end, simultaneous reduction of the aldehyde
(3) For selected examples of Lewis acid mediated intramolecular
electrophilic aromatic substitution reactions using unsaturated carbonyl
compounds, see: endo carbonyl (a) Smith, L. I.; Prichard, W. W. J. Am.
Chem. Soc. 1940, 62, 778. (b) Colonge, J.; Chambard, R. Bull. Soc. Chem.
Fr. 1953, 982. (c) Parham, W. E.; Wheeler, E. L.; Dodson, R. M. J. Am.
Chem. Soc. 1955, 77, 1166. (d) Pandey, R. C.; Dev, S. Tetrahedron 1968,
24, 3829. (e) Dawson, M. I.; Hobbs, P. D.; Derdzinski, K.; Chan, R. L.;
Gruber, J.; Chao, W.; Smith, S.; Thies, R. W.; Schiff, L. J. J. Med. Chem.
1984, 27, 1516. (f) Janusz, J. M.; Young, P. A.; Scherz, M. W.; Enzweiler,
K.; Wu, L. I.; Gan, L.; Pikul, S.; McDow-Dunham, K. L.; Johnson, C. R.;
Senanayake, C. B.; Kellstein, D. E.; Green. S. A.; Tulich, J. L.; Rosario-
Jansen, T.; Magrisso, I. J.; Wehmeyer, K. R.; Kuhlenbeck, D. L.; Eichold,
T. H.; Dobson, R. L. M. J. Med. Chem. 1998, 41, 1124. (g) Bergman, J.;
Venemalm, L.; Gogoll, A. Tetrahedron 1990, 46, 6067. (h) Nagao, Y.; Lee,
W. S.; Komaki, Y.; Sano, S.; Shiro, M. Chem. Lett. 1994, 597. (i) Ho,
T.-L.; Yang, P.-F. Tetrahedron 1995, 51, 181. exo carbonyl (j) Stork, G.;
Burgstahler, A. J. Am. Chem. Soc. 1951, 73, 3544. (k) Murphy, W. S.;
Watanasin, S. J. Chem. Soc., Perkin Trans. 1 1980, 1555. (l) Jung, M. E.;
Lam, P. Y.-S.; Mansuri, M. M.; Speltz, L. M. J. Org. Chem. 1985, 50,
1087. (m) Kashihara, H.; Shinoki, H.; Suemune, H.; Sakai, K. Chem. Pharm.
Bull. 1986, 11, 4527. (n) Hauser, F. M.; Caringal, Y. J. Org. Chem. 1990,
55, 555.
(4) For the photocyclization of a 2-(benzamido)acrylates, see: (a) Schultz,
A. G.; Sha, C.-K. Tetrahedron 1980, 36, 1757. (b) Naito, T.; Ninomiya, I.
Heterocycles 1988, 27, 1325. (c) Pyne, S. G.; Schafer, K. Tetrahedron 1998,
54, 5709. For the intramolecular Heck reactions of 2-{N-[(iodoaryl)alkyl]-
N-(tert-butoxycarbonyl)-amino}acrylates, see: (d) Gibson, S. E.; Guillo,
N.; Middleton, R. J.; Thuilliez, A.; Tozer, M. J. J. Chem. Soc., Perkin Trans.
1 1997, 447.
(5) Prepared in two steps from tris(hydroxymethyl)aminomethane hy-
drochloride. Hoppe, D.; Schmincke, H.; Kleemann, H.-W. Tetrahedron
1989, 45, 687.
Acknowledgment. We appreciate the financial support
provided by the National Institutes of Health (GM28553).
Supporting Information Available: Spectroscopic data
and experimental details for the preparation of all new
compounds. This material is available free of charge via the
OL016592N
(7) 3-Benzazocine analogues of morphine similar to 16 but lacking the
dihydrofuran ring have been previously reported; see: (a) Pecherer, B.;
Stumpf, J.; Brossi, A. HelV. Chim. Acta 1970, 53, 763. (b) Hori, M.;
Kataoka, T.; Shimizu, H.; Imai, E.; Koide, T.; Iwata, N.; Kurono, M. Chem.
Pharm. Bull. 1990, 38, 8. (c) Lai, B.; Bhedi, D. N.; Gidwani, R. M.; Sankar,
C. Tetrahedron 1994, 50, 9167 and ref 1 therein. Moreover, molecular
mechanics calculations suggest that the dihydrofuran ring as well as the
hydroxymethyl substituent of 14 contribute to the significant population of
the morphine-like conformer shown (0.75 kcal/mol above global minimum,
8% of a Boltzmann distribution of all conformers at 300 °K).
(6) Hendrickson, J. B.; Bergeron, R.; Sternbach, D. D. Tetrahedron 1975,
31, 2517. (b) Hendrickson, J. B.; Bair, K. W.; Bergeron, R.; Giga, A.;
Skipper, P. L.; Sternbach, D. D.; Wareing, J. A. Org. Prep. Proced. Int.
1977, 9, 173.
(8) Benzazocines 14 and 16 have been submitted for biological evalu-
ation. These studies will be reported separately.
Org. Lett., Vol. 3, No. 21, 2001
3351